Mark Schactman

2.9k total citations · 1 hit paper
16 papers, 2.0k citations indexed

About

Mark Schactman is a scholar working on Cardiology and Cardiovascular Medicine, Neurology and Epidemiology. According to data from OpenAlex, Mark Schactman has authored 16 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Neurology and 3 papers in Epidemiology. Recurrent topics in Mark Schactman's work include Cardiac Imaging and Diagnostics (2 papers), Substance Abuse Treatment and Outcomes (2 papers) and Opioid Use Disorder Treatment (2 papers). Mark Schactman is often cited by papers focused on Cardiac Imaging and Diagnostics (2 papers), Substance Abuse Treatment and Outcomes (2 papers) and Opioid Use Disorder Treatment (2 papers). Mark Schactman collaborates with scholars based in United States, Canada and Australia. Mark Schactman's co-authors include Bruce Thompson, Carolyn H. McCabe, Christopher P. Cannon, Eugene Braunwald, G. Fischer, Christopher Thompson, Elliott M. Antman, Milenko J. Tanasijevic, Anthony Fung and Donald R. Wybenga and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Mark Schactman

15 papers receiving 1.9k citations

Hit Papers

Cardiac-Specific Troponin I Levels to Predict the Risk of... 1996 2026 2006 2016 1996 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Schactman United States 9 1.7k 859 534 134 110 16 2.0k
H. D. White New Zealand 21 1.4k 0.8× 454 0.5× 503 0.9× 170 1.3× 83 0.8× 46 1.8k
X. H. Krauss Netherlands 20 1.8k 1.1× 747 0.9× 808 1.5× 146 1.1× 183 1.7× 39 2.4k
Normand Racine Canada 23 1.9k 1.1× 629 0.7× 596 1.1× 140 1.0× 112 1.0× 86 2.5k
Martin Gottwik Germany 24 1.5k 0.9× 481 0.6× 707 1.3× 82 0.6× 173 1.6× 90 2.3k
Francesco Barillà Italy 25 1.5k 0.9× 522 0.6× 515 1.0× 265 2.0× 234 2.1× 152 2.4k
Elliot M. Antman United States 19 1.2k 0.7× 292 0.3× 371 0.7× 103 0.8× 81 0.7× 36 1.5k
Raymond T. Yan Canada 32 2.8k 1.7× 997 1.2× 864 1.6× 187 1.4× 214 1.9× 95 3.5k
G. Fischer United States 11 1.2k 0.7× 704 0.8× 457 0.9× 185 1.4× 128 1.2× 25 2.0k
Sergio Raposeiras‐Roubín Spain 28 1.7k 1.0× 365 0.4× 480 0.9× 121 0.9× 275 2.5× 188 2.5k
Alan G. Wasserman United States 26 1.8k 1.1× 608 0.7× 549 1.0× 157 1.2× 111 1.0× 48 2.4k

Countries citing papers authored by Mark Schactman

Since Specialization
Citations

This map shows the geographic impact of Mark Schactman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Schactman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Schactman more than expected).

Fields of papers citing papers by Mark Schactman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Schactman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Schactman. The network helps show where Mark Schactman may publish in the future.

Co-authorship network of co-authors of Mark Schactman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Schactman. A scholar is included among the top collaborators of Mark Schactman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Schactman. Mark Schactman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wu, Li‐Tzy, Jacquie King, Kathryn Hefner, et al.. (2024). Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists. Addiction Science & Clinical Practice. 19(1). 88–88.
2.
D’Onofrio, Gail, Andrew A. Herring, Jeanmarie Perrone, et al.. (2024). Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal. JAMA Network Open. 7(7). e2420702–e2420702. 12 indexed citations
3.
Beaulieu, Danielle, James D. Berry, Sabrina Paganoni, et al.. (2021). Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 22(sup1). 22–32. 8 indexed citations
4.
Brooks, Benjamin Rix, Erik P. Pioro, Danielle Beaulieu, et al.. (2021). Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 23(1-2). 49–57. 4 indexed citations
5.
Packer, Milton, Christopher M. O’Connor, John J.V. McMurray, et al.. (2017). Effect of Ularitide on Cardiovascular Mortality in Acute Heart Failure. New England Journal of Medicine. 376(20). 1956–1964. 193 indexed citations
6.
Wittes, Janet & Mark Schactman. (2014). On independent data monitoring committees in oncology clinical trials.. PubMed. 3(3). 40–40. 7 indexed citations
7.
Perez, Alejandra, Banu Arun, Debu Tripathy, et al.. (2010). A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Research and Treatment. 120(1). 111–118. 75 indexed citations
8.
Cannon, Christopher P., Carolyn H. McCabe, Peter H. Stone, et al.. (1997). Circadian Variation in the Onset of Unstable Angina and Non-Q-Wave Acute Myocardial Infarction (The TIMI III Registry and TIMI IIIB). The American Journal of Cardiology. 79(3). 253–258. 99 indexed citations
10.
Scott, Christopher G., Mark Schactman, & L. Michael Graver. (1997). Aortic valve replacement with a pulmonary autograft: case studies of the Ross procedure. American Journal of Critical Care. 6(6). 418–422. 3 indexed citations
11.
Antman, Elliott M., Milenko J. Tanasijevic, Bruce Thompson, et al.. (1996). Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary Syndromes. New England Journal of Medicine. 335(18). 1342–1349. 1291 indexed citations breakdown →
12.
Stone, Peter H., Bruce Thompson, Marvin W. Kronenberg, et al.. (1996). Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry.. PubMed. 275(14). 1104–12. 97 indexed citations
13.
Schactman, Mark, et al.. (1994). Chylopericardium following aortic valve replacement and coronary artery bypass surgery: a case report and discussion. American Journal of Critical Care. 3(4). 313–315. 2 indexed citations
14.
Schactman, Mark, et al.. (1993). Rhythm disturbances in the patient with pulmonary disease. Critical Care Nurse. 13(3). 40–46. 1 indexed citations
15.
Schactman, Mark, et al.. (1991). Signal-averaged electrocardiography: a new technique for determining which patients may be at risk for sudden cardiac death.. PubMed. 18(3). 202–3, 206, 209 passim. 1 indexed citations
16.
Schactman, Mark. (1987). Transfer stress in patients after myocardial infarction.. PubMed. 14(2). 34–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026